LifeStance Health (LFST) Receivables - Other (2021 - 2025)

LifeStance Health has disclosed Receivables - Other across 5 years of filings, most recently posting $3.8 million for Q4 2025.

• In Q4 2025, Receivables - Other rose 1599.55% year-over-year to $3.8 million; the TTM figure through Dec 2025 stood at $3.8 million (up 1599.55% YoY), while the FY2025 annual figure was $3.8 million, up 1599.55% from the prior year.
• Receivables - Other rose to $3.8 million in Q4 2025, from $223000.0 in the prior quarter.
• Over the last five years, Receivables - Other for LFST reached as high as $19.3 million in Q4 2021 and fell as low as $223000.0 in Q4 2024.
• The 5-year median for Receivables - Other is $3.8 million (2025), against an average of $4.7 million.
• Annual changes were most pronounced in 2022 — Receivables - Other slumped 96.68% — and 2025, when it soared 1599.55%.
• A 5-year view of Receivables - Other shows it stood at $19.3 million in 2021, then tumbled by 96.68% to $640000.0 in 2022, then sank by 63.28% to $235000.0 in 2023, then retreated by 5.11% to $223000.0 in 2024, then soared by 1599.55% to $3.8 million in 2025.
• According to Business Quant data, Receivables - Other over the past three periods registered $3.8 million, $223000.0, and $235000.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.